Home » Get Involved » Advocate for Us » Explore the National Action Plan
NeuroEndocrine Cancer Australia believes advocacy is the best way forward to get greater access to optimal patient care. Our National Action Plan has been developed in collaboration with key stakeholders, patients, the consumer advisory group, Centres of Excellence and leading Healthcare Specialists right across Australia to develop a clear strategy that we will present to the government for better neuroendocrine cancer education, treatment and support.
Now we need the help of our NETs community to call upon their local MP’s across the country and ask for their support.
The purpose of the National Action Plan is to inform stakeholders, particularly those in policy making, health and government, about the incidence of neuroendocrine cancers in Australia and their impact and cost to individuals, families, carers and the economy.
Under the guidance of Neuroendocrine Cancer Australia, the National Action Plan has been developed to establish, consolidate and expand 8 key areas of focus over the next five-year period.
We believe one of the best ways to get your voice heard by the government is to let your local MP know the issues people are facing in their own electorate. As your representative, it is their job to listen.
By working together, we can make a difference. With over 29,350+ Australians living with NETs the time to act is now.
From little things big things grow, and after 14 years of connecting with our community, now is the time to approach the government with one strong united voice to ensure that in the future, no patient with a neuroendocrine tumour slips through the NET.
Please contact your local Member of Parliament and tell them why you believe they need to do more for neuroendocrine cancer patients.
You can do this by email, mail, phone – or all three! We’ve created some templates below to help get you started.
Our Consumer Advisory Group are here to help should you have any questions. Click the member for your state for assistance.